Clinical Trials Sponsored by G.A.P. Hospers

Total 86 results

G.A.P. Hospers

Completed

AR and ER Imaging in Metastatic Breast Cancer

Metastatic Breast Cancer

Netherlands
Hoopes Vision
Alcon Research

Recruiting

Contralateral Study of Topography Guided LASIK Versus Small Incision Lenticule Extraction

Astigmatism | Myopia

United States
Ingrid Hopper
HBA

Completed

Screening Evaluation of the Evolution of New Heart Failure (SCREEN-HF)

Heart Failure

Australia
Steve H. Linn, OD

Completed

The Comparison of Cataract Lasers Using the Optimedica Catalys Laser and the Alcon LenSx Laser.

Cortical Cataract | Posterior Subcapsular Cataract | Nuclear Sclerosis of the Lens

United States
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Pharmacokinetics (PK) and Pharmacodynamics (PD) of Mayne Glucagon for Injection Compared With Glucagen® (Novo Nordisk) in Healthy Volunteers

Hypoglycemia

United Kingdom
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Biosimilar Retacrit™ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology

Multiple Myeloma | Solid Tumours | Malignant Lymphomas | Chemotherapy-induced Symptomatic Anaemia

Germany
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Nivestim™ in Treatment of Malignant Diseases

Solid Tumour | Malignant Haematological Tumour | Primary or Secondary Prophylactic Treatment

Germany
Hospira, now a wholly owned subsidiary of Pfizer

Completed

A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)

Anesthesia | Surgical Procedures, Elective

United States
Hospira, now a wholly owned subsidiary of Pfizer

Terminated

Safety and Efficacy of PMI-150 (Intranasal Ketamine) for the Treatment of Breakthrough Pain in Cancer Patients

Pain | Cancer

United States
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Open-Label, Safety, and Efficacy Study of Dexmedetomidine in Preterm Subjects Ages ≥28 Weeks to <36 Weeks Gestational Age

Anesthesia

United States
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Pharmacokinetic/Pharmacodynamic (PK/PD) Study Evaluating Pegfilgrastim Hospira Compared to Neulasta (Amgen) in Healthy Volunteers

Healthy

United Kingdom
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Open-Label, Safety Study Evaluating the Use of Dexmedetomidine in Pediatric Subjects Undergoing Procedure-Type Sedation

Ultrasound | CT Scans | MRIs

United States, Puerto Rico
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Biosimilar Retacrit® in the Treatment of Chemotherapy-induced Anaemia in Oncology and Haematology (SYNERGY)

Chemotherapy-induced Anemia

France
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Safety and Efficacy of Repeated Doses of PMI-150 (Intranasal Ketamine) in Acute Post-operative Pain Following Orthopedic Surgery

Pain, Postoperative

United States
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Epoetin Alfa Biosimilar in the Management of Chemotherapy-Induced Symptomatic Anemia in Haematology and Oncology (ORHEO)

Solid Tumors | Lymphomas | Chemotherapy-induced Symptomatic Anemia | Malignant Hemopathies | Myelomas

France
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in Pediatrics Subjects

Intubated and Mechanically Ventilated Pediatric Subjects

United States, Guatemala
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Bioequivalency Study Comparing Hospira's Generic Iron Sucrose Injection to Venofer

Healthy Volunteers

United States
Hospira, now a wholly owned subsidiary of Pfizer

Withdrawn

A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Heart Surgery

Delirium

United States
Hospira, now a wholly owned subsidiary of Pfizer

Completed

The Pharmacokinetics and Safety Characteristics of Docetaxel in Patients With Cancer

Cancer

United Kingdom, Russian Federation
Hospira, now a wholly owned subsidiary of Pfizer

Completed

A Study Comparing the Effects of Epoetin Hospira and Epogen/Epoetin Alfa (Amgen) When Administered IV in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment

Chronic Renal Failure

United States
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Safety and Efficacy of Dexmedetomidine (DEX) in Intubated and Mechanically Ventilated Pediatric Intensive Care Unit (PICU) Subjects

Sedation

United States, Canada
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Safety, Efficacy and Pharmacokinetic Study of Dexmedetomidine in Pediatrics Ages ≥28 Weeks to ≤44 Weeks Gestational Age

Sedation

United States, Guatemala
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents

Solid Tumors | Malignant Hemopathy | Chemotherapy-induced Febrile Neutropenia (FN)

France
Hospira, now a wholly owned subsidiary of Pfizer

Completed

A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation for Elective Awake Fiberoptic Intubation

Awake Fiberoptic Intubation

United States
Hospira, now a wholly owned subsidiary of Pfizer

Completed

A Randomized, Single-Dose, Comparative, Positive and Placebo Controlled, Four-Way, Four Period, Cross-Over Study to Evaluate the Effect of DIC075V on QTc Intervals in Healthy Subjects

Ventricular Repolarization

United States
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Phase II Pharmacokinetic and Pharmacodynamic Study of DEX in Subjects Aged 12 Months Through <24 Months

Pain | Sedation

United States
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Study to Evaluate Hemodynamic Effect of Different Loading Doses of Precedex in Post-surgical Intensive Care Unit (ICU) Patients

Intensive Care Unit

Canada
Hospira, now a wholly owned subsidiary of Pfizer

Terminated

A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery

Delirium

United States
Hospira, now a wholly owned subsidiary of Pfizer

Completed

A Safety and Efficacy Study of Dexmedetomidine in ICU Patients Requiring Continuous Sedation

Mechanically Ventilated and Intubated Subjects

United States, Australia, Argentina, Brazil, New Zealand
Pfizer
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO II)

Pregnancy | Lactation | Renal Anemia

France, Croatia, Spain, United Kingdom, Germany, Sweden, Bulgaria, Greece, Denmark, Finland, Ireland, Italy
Pfizer
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From Remicade (PERSIST)

Rheumatoid Arthritis | Psoriatic Arthritis | Ankylosing Spondylitis | Rheumatoid Diseases

Spain, Canada, Greece, United Kingdom, Germany, Bulgaria, Czechia
Pfizer
Hospira, now a wholly owned subsidiary of Pfizer

Terminated

Use of Biosimilar Nivestim® to Prevent Chemo-induced Neutropenia. Real Life Study (VISTA)

Chemotherapy-Induced Neutropenia

France
Pfizer
Hospira, now a wholly owned subsidiary of Pfizer

Completed

A Phase 3 Study Comparing the Effects of Intravenous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin (AiME - 01)

Chronic Kidney Disease | Chronic Renal Failure

United States, Puerto Rico
Pfizer
Hospira, now a wholly owned subsidiary of Pfizer

Completed

A Research Study To Test How Multiple Doses Of Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given by Subcutaneous Injection (SC) (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen)

Neutropenia (Low White Blood Cell Count)

United States
Pfizer
Hospira, now a wholly owned subsidiary of Pfizer

Completed

A Comparative Study to Evaluate the Effect of HSP-130, US-approved Neulasta and EU-approved Neulasta in Healthy Participants

Neutropenia

Australia
Pfizer
Hospira, now a wholly owned subsidiary of Pfizer

Completed

A Research Study To Test How Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given By Subcutaneous Injection (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen)

Neutropenia (Low White Blood Cell Count)

United States
Pfizer
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease (CONNECT-IBD)

Inflammatory Bowel Diseases | Crohn's Disease | Ulcerative Colitis

France, Spain, United Kingdom, Czechia, Italy, Belgium, Germany, Netherlands, Greece, Finland, Hungary, Portugal, Slovakia
Pfizer
Hospira, now a wholly owned subsidiary of Pfizer

Completed

A Study Of The Safety And Effects Of One Or More Doses Of HSP-130 Injected Under The Skin In Women With Breast Cancer That Has Not Spread To Distant Sites In The Body.

Non-metastatic Breast Cancer

Hungary, Spain
Pfizer
Hospira, now a wholly owned subsidiary of Pfizer

Completed

A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin (AiME - 13)

Chronic Kidney Disease | Chronic Renal Failure

United States
Pfizer
Hospira, now a wholly owned subsidiary of Pfizer

Completed

A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis

Chronic Kidney Disease (CKD)

United States, Puerto Rico
University Health Network, Toronto
Shoppers Drug Mart; integrated medhealth communication

Recruiting

Real-World Evidence in Patient-Reported Outcomes for Medical Cannabis (MC-RWE) (MC-RWE)

Depression | Epilepsy | Pain | Sleep | Anxiety

Canada
Durect
Hospira, now a wholly owned subsidiary of Pfizer; Nycomed

Completed

An Extension Trial to Evaluate Long-term Safety of SABER™-Bupivacaine for Pain Following Shoulder Surgery

Pain

New Zealand, Australia
Hospira, now a wholly owned subsidiary of Pfizer
Maruishi Pharmaceutical

Completed

Post-Marketing Clinical Study to Assess Efficacy and Safety of Dexmedetomidine in Post-Operative Patients

Conscious Sedation

Japan
Yale University
Hospira, now a wholly owned subsidiary of Pfizer

Completed

A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies

Hematologic Malignancies

United States
Hospira, now a wholly owned subsidiary of Pfizer
Maruishi Pharmaceutical

Completed

Clinical Study to Investigate the Efficacy and the Safety of DA-9501 in Sedation During the Surgery or Medical Procedure Without Intubation

Sedation

Japan
Hospira, now a wholly owned subsidiary of Pfizer
Maruishi Pharmaceutical

Completed

Long-term Clinical Study Evaluating the Safety and Efficacy of Dexmedetomidine in ICU Subjects

Sedation

Japan
Stanford University
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Postoperative Pain and Functional Patient Outcomes After Functional Endoscopic Sinus Surgery

Pain, Postoperative

United States
Austin Health
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Dexmedetomidine to Lessen Intensive Care Unit (ICU) Agitation (DahLIA)

Delirium

Australia
Durect
Hospira, now a wholly owned subsidiary of Pfizer; Nycomed

Completed

Bupivacaine Effectiveness and Safety in SABER® Trial (BESST)

Postoperative Pain | Abdominal Surgery

United States, Australia, New Zealand
Duke University
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Cerebral Perfusion Pressure Using Precedex and Other Sedatives (C3PO)

Endotracheal Intubation | Continuous IV Sedation | ICP Monitoring

United States

Clinical Trials Sponsored by G.A.P. Hospers

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations